Gabriella Camboni

984 citations

26 papers · 821 indexed · h-index 17

Co-authors: Giovanna Damia P.A. Bianchi Silvia Marsoni Guido Basilisco A. Bernareggi Duncan I. Jodrell Alexander Berndt Maurizio D’Incalci
Topics: Cancer Treatment and Pharmacology (6 papers)Lung Cancer Treatments and Mutations (5 papers)Gastroesophageal reflux and treatments (3 papers)
Cited by: Gastroenterology Oncology Pathology and Forensic Medicine
Journals: Journal of Clinical Oncology Cancer Research Gut
Partner nations: Italy United Kingdom Germany

In The Last Decade

Gabriella Camboni

25 papers receiving 797 citations

Peers

Countries citing papers authored by Gabriella Camboni

Since Specialization

Citations

This map shows the geographic impact of Gabriella Camboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Camboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Camboni more than expected).

Fields of papers citing papers by Gabriella Camboni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Camboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Camboni. The network helps show where Gabriella Camboni may publish in the future.

Co-authorship network of co-authors of Gabriella Camboni

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Camboni. A scholar is included among the top collaborators of Gabriella Camboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Camboni. Gabriella Camboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of improved signal peptides for heterologous expression in Saccharomyces using a screen that exploits Gaussia luciferase 2025 ·Scientific Reports ·Gabriella Camboni,Jared Cartwright,Gideon Grogan	2
2	The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts 2012 ·Molecular Cancer Therapeutics ·Ezia Bello,Giulia Taraboletti,Gennaro Colella,Massimo Zucchetti,(unknown),Simonetta Andrea Licandro,Alexander Berndt,Petra Richter,Maurizio D’Incalci,Ennio Cavalletti,Raffaella Giavazzi,Gabriella Camboni,Giovanna Damia	39
3	E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models 2011 ·Cancer Research ·Ezia Bello,Gennaro Colella,(unknown),Paolo Oliva,Alexander Berndt,Giovanni Valbusa,Sonia Colombo Serra,Maurizio D’Incalci,Ennio Cavalletti,Raffaella Giavazzi,Giovanna Damia,Gabriella Camboni	117
4	Abstract 1367: The dual selective VEGFR-FGFR kinases inhibitor E-3810 decreases tumor perfusion and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging 2010 ·Cancer Research ·Francis Bichat,Xavier Tizon,(unknown),(unknown),(unknown),Gabriella Camboni,Ennio Cavalletti	2
5	A work in progress: The clinical development of histone deacetylase inhibitor 2008 ·Epigenetics ·Silvia Marsoni,Giovanna Damia,Gabriella Camboni	68
6	A phase I study of the trinuclear platinum compound, BBR�3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer 2004 ·Cancer Chemotherapy and Pharmacology ·Charlie Gourley,James T. Cassidy,(unknown),Leslie Samuel,D. Bisset,Gabriella Camboni,Anne Marie Young,(unknown),Duncan I. Jodrell	19
7	Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma 2004 ·European Journal of Cancer ·Duncan I. Jodrell,T.R. Jeffry Evans,William P. Steward,David Cameron,J Prendiville,C. Aschele,Cristina Noberasco,Michael Lind,J Carmichael,Nicola Dobbs,Gabriella Camboni,(unknown),Filippo de Braud	104
8	P-523 Phase II trial of BBR3464, a novel, bifunctional platinum analog, as second line treatment of non-small cell lung cancer patients 2003 ·Lung Cancer ·Giorgio V. Scagliotti,Silvia Novello,Lucio Crinò,Filippo de Marinis,Maurizio Tonato,Cristina Noberasco,Giovanni Selvaggi,(unknown),(unknown),Gabriella Camboni	11
9	Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin’s lymphoma 2001 ·Annals of Oncology ·Peter Borchmann,R. Schnell,(unknown),Jan Oliver Staak,Gabriella Camboni,A. Bernareggi,Kai Hübel,Peter Staib,Alexander Schulz,Volker Diehl,Andreas Engert	44
10	Phase II trial of BBR3464, a novel, bifunctional platinum analog, in advanced but favorable out-come, Non Small Cell Lung Cancer patients 2001 ·European Journal of Cancer ·Giorgio V. Scagliotti,(unknown),Filippo de Marinis,Maurizio Tonato,Giovanni Selvaggi,Francesco Massoni,A Maestri,(unknown),Gabriella Camboni	3
11	Phase II clinical study of BBR 3464, a novel, bifunctional platinum analogue, in patients with advanced ovarian cancer 2001 ·European Journal of Cancer ·A H Calvert,H. Thomas,N. Colombo,M. Gore,Helena Earl,(unknown),Gabriella Camboni,P. Liati,Cristiana Sessa	35
12	A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly 2000 ·European Journal of Cancer ·L. Dawson,Duncan I. Jodrell,A. Bowman,Ron Rye,(unknown),A. Bernareggi,Gabriella Camboni,John F. Smyth	33
13	Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex 2000 ·Annals of Oncology ·Cristiana Sessa,Giuseppe Capri,Luca Gianni,Fedro A. Peccatori,Giacomo Grasselli,Jean Bauer,Massimo Zucchetti,Lucia Viganò,Anna Gatti,Carla Minoia,P. Liati,S. Van den Bosch,A. Bernareggi,Gabriella Camboni,Silvia Marsoni	59
14	Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger‐Ellison syndrome and antral G‐cell hyperfunction 1994 ·Alimentary Pharmacology & Therapeutics ·Bruno Annibale,G. Delle Fave,Cinzia Azzoni,Vito D. Corleto,Gabriella Camboni,G. D’Ambra,Francesco Paolo Pilato,Cesare Bordi	16
15	Orocecal transit delay in obese patients 1989 ·Digestive Diseases and Sciences ·Guido Basilisco,Gabriella Camboni,(unknown),(unknown),S. B. Doldi,P.A. Bianchi	39
16	Intragastric and intraoesophagel pH monitoring in duodenal ulcer patients: effect of the new histamine H2-receptor antagonist ramixotidine 1989 ·European Journal of Clinical Pharmacology ·(unknown),Guido Basilisco,(unknown),Gabriella Camboni,Paolo A. Bianchi	1
17	Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit 1988 ·Digestive Diseases and Sciences ·Gabriella Camboni,Guido Basilisco,(unknown),P.A. Bianchi	21
18	Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A) 1988 ·European Journal of Clinical Pharmacology ·M Colle,(unknown),Jean‐Pierre Cazenave,(unknown),Guido Basilisco,Gabriella Camboni,L. Manara	1
19	Lactose malabsorption and intolerance in Italians 1986 ·Digestive Diseases and Sciences ·(unknown),Roberto Penagini,P. Velio,Gabriella Camboni,(unknown),M Quatrini,D. Conte,Paolo A. Bianchi	34
20	Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test. 1985 ·Gut ·Guido Basilisco,(unknown),Gabriella Camboni,M. Recchia,M Quatrini,D. Conte,Roberto Penagini,P.A. Bianchi	50

About Gabriella Camboni

Gabriella Camboni is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 821 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Gastroesophageal reflux and treatments (3 papers). The work is most often cited by research in Gastroenterology (108 citations), Oncology (341 citations) and Pathology and Forensic Medicine (139 citations). Gabriella Camboni has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Giovanna Damia, P.A. Bianchi, Silvia Marsoni, Guido Basilisco, A. Bernareggi, Duncan I. Jodrell, Alexander Berndt, Maurizio D’Incalci, Raffaella Giavazzi and Gennaro Colella. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact